You can plan a clinical trial meticulously but when you start a First-in-Human study prepare to be flexible!

Richmond Pharmacology has extensive experience of conducting First-in-Human clinical trials, including studies involving biologics, and we have a very experienced team on hand to help you. You can be sure we will rise to the occasion.

View Case Study

Data Management Case Study - April 09

Richmond Pharmacology has extensive experience in the conduct of intensive thorough QTc studies. We are proud to offer a dedicated, highly skilled team within an efficient and safe hospital environment, using state of the art technology.

View Case Study

Data Management Case Study - March 09

Timelines, Tight Timelines, And Even Tighter Timelines In A Phase I Environment.

View Case Study

The Richmond Pharmacology Japanese Team commits to a challenging study...and they deliver.

Richmond Pharmacology has extensive experience in the conduct of intensive thorough QTc studies. We are proud to offer a dedicated, highly skilled team within an efficient and safe hospital environment, using state of the art technology.

View Case Study

65 Subjects Vaccinated in 1 day

Recruitment can sometimes be a challenge, however the tighter the timelines and the larger the group required, the more Richmond Pharmacology rises to the challenge.

View Case Study

“I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.”

- Anonymous

“Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.”

- Anonymous

“Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.”

- Anonymous

Latest news

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

January 19, 2023
Keith Berelowitz will be responsible for ensuring that all ethical possibilities are explored in relation to new research.
Read more

Unlocking the potential of data sharing

January 4, 2023
Dilshat Djumonov explores how GDPR is central to protecting private information while presenting unique challenges to the pharmaceutical clinical trials industry.
Read more

Events

13th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions

Sunday, June 4th to Tuesday June 6th 2023
Exchange research-based knowledge on drug-drug interactions (DDIs) among all interested stakeholders from pharmaceutical industry, regulatory authorities, academic and health care delivery backgrounds and perspectives.
View event